DiaSorin Company Research & Development Immunodiagnostic Solutions Molecular Solutions People Culture Investor Relations Immunodiagnostic Solutions more close Immunodiagnostic Solutions Clinical Areas Infectious Diseases Bone and Mineral Endocrinology Hypertension Oncology Stool Diagnostics Autoimmunity Cardiac and Brain Damages Systems CLIA ELISA Committed to efficiency DiaLink 3000 DiaBox LIAISON® XLine The broadest Infectious Disease menu Molecular Solutions close Molecular Solutions Systems Infectious Diseases Onco-hematology Events Focus Diagnostics Worldwide contacts more close Worldwide contacts Industrial Sites Branches Immunodiagnostics distributors Molecular diagnostics distributors At the booth At the booth Upcoming events Financial Marketing Past events News DiaSorin Scientific contribution at Euromedlab Athens DiaSorin launches the new LIAISON® XL Zika Capture IgM DiaSorin launches a new serology assay to be used with LIAISON® Analyzer Family: the LIAISON® H. pylori IgG DiaSorin scientific contribution at ECCMID Amsterdam 2016 DiaSorin makes Bordetella Pertussis and Brahms PCT II Gen tests available in Chemiluminescence DiaSorin scientific contribution at IFCC WorldLab DiaSorin launches the test for Calprotectin FDA approves 1,25 Vitamin D in the US market DiaSorin, the Diagnostic Specialist Educational more close Educational Clinical areas Educational videos Articles & posters U.S. Webinars DiaSorin Symposia Catalog Dialog Download DiaSorin app for laboratories Search form Search English Italiano DiaSorin S.p.A. - Share Capital € 55.948.257 R.E.A. 180729 Fiscal Code and Subscription to Vercelli Companies Register no 13144290155 Legal Notices Privacy Policy Modern Slavery Act Statement Scroll down ▼ close Android Iphone